Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies

Codolo, Gaia, Plotegher, Nicoletta, Pozzobon, Tommaso, Brucale, Marco, Tessari, Isabella, Bubacco, Luigi, de Bernard, Marina·2013·PLoS ONE

Cited by (587)

Items 501–587 of 587

  1. LRRK2-G2019S Synergizes with Ageing and Low-Grade Inflammation to Promote Gut and Peripheral Immune Cell Activation that Precede Nigrostriatal Degeneration
    Carmela Giachino, Cataldo Tirolo, Salvatore Caniglia, Maria Francesca Serapide, Francesca L’Episcopo, Federico Bertoli, Claudio Giuliano, Marika Mearelli, Meike Jakobi, Nicole Schneiderhan‐Marra et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  2. Complement C1q-dependent engulfment of alpha-synuclein induces ENS-resident macrophage exhaustion and accelerates Parkinson’s-like gut pathology
    Phillip M. Mackie, J Koshy, M Bhogade, T Hammoor, William Hachmeister, Grace M. Lloyd, Giavanna Paterno, MacKenzie L. Bolen, Malú G. Tansey, Benoit I. Giasson et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  3. The Interplay Between CB2 and NMDA Receptors in Parkinson’s Disease
    Irene Reyes‐Resina, Jaume Lillo, Iu Raïch, Joan Biel Rebassa, Toni Capó, Pau Badia, Gemma Navarro · 2025 · International Journal of Molecular Sciences
  4. Early diagnosis of Parkinson's disease pathogenesis using biofluidic biomarkers with a focus on α-synuclein
    N. Aghakhani, A. Arzoo, Bryce G. Dorflinger, Seyed Zanyar Athari, Gisou Mohaddes · 2025 · Brain Disorders
  5. C1q-dependent clearance of alpha-synuclein allows macrophages to transiently limit enteric synucleinopathy in male mice
    Phillip M. Mackie, Joanne M. Koshy, M Bhogade, T Hammoor, William Hachmeister, Grace M. Lloyd, Giavanna Paterno, MacKenzie L. Bolen, Andrea R. Merchak, Malú G. Tansey et al. · 2026 · Nature Communications
  6. Peripheral immunochemical considerations in Parkinson disease: sources, targets and crosstalk mechanisms
    Alessandra Castegna, Luna Laera, Piergianni Moda, Stefano Miglietta, Mariagrazia D’Agostino, Melania Ruggiero, Antonia Cianciulli, Francesca Martina Filannino, Chiara Porro, David Allan Butterfield et al. · 2026 · Journal of Translational Medicine
  7. Contribution of neuroinflammation, resolution, and neuroprotection in neuropsychiatric diseases
    A. A. Farooqui · 2021 · Elsevier eBooks
  8. Immunology and microbiome: Implications for motor systems
    Yasamin Mahjoub, Davide Martino · 2023 · Handbook of clinical neurology
  9. The use of gold nanoparticles in the treatment of neurodegenerative diseases
    Gustavo de Bem Silveira, Laura de Roch Casagrande, Ligia Milanez Venturini, Jade de Oliveira, Paulo César Lock Silveira · 2024 · Elsevier eBooks
  10. Sinapic Acid Improves Neurotransmitter Status and Oxidative Stress-Related Changes in Mouse Model of Experimental Parkinsonism
    Preeja Prabhakar, Abdul Bakrudeen Ali Ahmed, Saravana Babu Chidambaram, Arun Kumar Ramu, Arjun Pandian · 2023 · International journal of Nutrition Pharmacology Neurological Diseases
  11. Neuroinflammation-mediated white matter injury in Parkinson’s disease and potential therapeutic strategies targeting NLRP3 inflammasome
    Linglong Xiao, Mengqi Wang, Yifeng Shi, Xinyuejia Huang, Wei Zhang, Yang Wu, Hao Deng, Botao Xiong, Wei Pan, Jie Zhang et al. · 2024 · International Immunopharmacology
  12. Immunity in Parkinson's disease – The role of innate responses
    Aditi S Iyengar, Peter Robert Dunkley, Phillip W. Dickson · 2025 · Journal of Neuroimmunology
  13. Immune Sensors and Effectors of Health and Disease
    Manmeet K. Mamik, Christopher Power · 2016 · Springer eBooks
  14. Contribution of neuroinflammation, resolution, and neuroprotection in neurodegenerative diseases
    A. A. Farooqui · 2021 · Elsevier eBooks
  15. A Role for the Regulation of the Melatonergic Pathways in Alzheimer’s Disease and Other Neurodegenerative and Psychiatric Conditions
    George Anderson, Michael H. J. Maes · 2016 · CRC Press eBooks
  16. Endogenous DAMPs, Category I: Constitutively Expressed, Native Molecules (Cat. I DAMPs)
    Walter Gottlieb Land · 2018 · Springer eBooks
  17. Neuroprotection: The Way of Anti-Inflammatory Agents
    Patrice Mendel Nzogang, Donkeng J. Martial · 2020 · IntechOpen eBooks
  18. Alpha-synuclein and neuroinflammation in Parkinson's disease
    Tatiana Varanita, Luigi Bubacco · 2020 · Elsevier eBooks
  19. DES-Amyloidoses “Amyloidoses through the looking-glass”: A knowledgebase developed for exploring and linking information related to human amyloid-related diseases
    Vladan Bajić, Adil Salhi, Katja Lakota, Aleksandar Radovanović, Rozaimi Razali, Lada Živković, Biljana Spremo‐Potparević, Mahmut Uludağ, Faroug Tifratene, Olaa Motwalli et al. · 2022 · PLoS ONE
  20. Genetic mitochondrial glycine amidinotransferase protein aggregate formation triggers microparticle sensing and kidney failure
    Shrikant R. Mulay, Hans‐Joachim Anders · 2018 · Annals of Translational Medicine
  21. Gut–Brain Axis: Role of Gut Microbiota in Neurodegenerative Disease
    Aarti Narang, Rajat Sandhir · 2022 · Springer eBooks
  22. P2RX7, an adaptive immune response gene, is associated with Parkinson's disease risk and age at onset
    Shachar Shani, Mali Gana‐Weisz, Anat Bar‐Shira, Avner Thaler, Tanya Gurevich, Anat Mirelman, Nir Giladi, Roy N. Alcalay, Avi Orr‐Urtreger, Orly Goldstein · 2024 · Journal of Parkinson s Disease
  23. Parkinson's disease: A chronic systemic inflammatory disorder
    Hina Khan, Matthew J. Benskey · 2025 · Handbook of behavioral neuroscience
  24. Curcumin as a modulator of IL-18: A promising therapeutic approach for inflammatory diseases
    Maryam Kavyani, Sahar Ghoflchi, Saba Miri Disfani, Mohammad Jalili‐Nik, Asie Sadeghi, Sercan Karav, Prashant Kesharwani, Hossein Hosseini, Amirhossein Sahebkar · 2025 · Food Bioscience
  25. Interplay of oxidative stress and Inflammasome activation and clinical indices in Parkinson’s disease: insights from serum SIRT1, Nrf2, and NLRP3 levels and PDQ-39—a cross-sectional study
    Khlood Mohammad Aldossary, Eman Hamza, Mostafa M. Kamel, Amsha S. Alsegiani, Sarah Alrubia, Wedad S. Sarawi, Eman El‐Khateeb, Nashwa Eltantawy, Shereen A. Mourad, Nora Elshorbagi et al. · 2026 · Frontiers in Neuroscience
  26. iPSC-derived microglia: Decoding roles and therapeutic opportunities in neurodegenerative diseases
    Didi Shan, Hongxu Wang, Jianing Li, Yao Tang, Zexin Zhan, Chuanzhu Yan, Jingwen Xu, Fuchen Liu · 2026 · Brain Research Bulletin
  27. Repurposing Antidiabetic Medications for Parkinson’s Disease: Focus on Biomarker Strategies for Disease Modification
    Narayana K. Yelleswarapu, Christos Sidiropoulos · 2026 · International Journal of Molecular Sciences
  28. Mechanism and regulation of programmed cell death in aging-related diseases
    Xingxing Xie, Daichao Xu · 2026 · Cell chemical biology
  29. Research progress on the α-synuclein-lysosome axis in Parkinson’s disease: molecular mechanisms of protein aggregation, autophagy dysfunction, and therapeutic targeting
    Jiaojiao Fu, Chuanxi Zhu, Zhenzhen Fan · 2026 · Frontiers in Neuroscience
  30. Role of the NLRP3 Inflammasome in Periodontal Disease: A Tour d'horizon
    Pradeep Koppolu, Rasheed Abdulsalam · 2022 · Research Journal of Pharmacy and Technology
  31. Accumulation of Alpha-Synuclein and Increase in the Inflammatory Response in the substantia nigra, Jejunum, and Colon in a Model of O3 Pollution in Rats
    Marlen Valdés‐Fuentes, Erika Rodrı́guez-Martı́nez, Selva Rivas-Arancibia · 2024 · International Journal of Molecular Sciences
  32. Insulin and toll-like receptor 4 interaction in the rat model of Parkinson’s disease induced by lipopolysaccharide
    Fatemeh Hemmati, Neda Valian, Abolhassan Ahmadiani, Zahurin Mohamed, Azman Ali Raymond, Norlinah Mohamed Ibrahim, Seyed Farshad Hosseini Shirazi · 2024 · Physiology and Pharmacology
  33. Characterisation of Oxidative Stress, DNA Damage and Inflammation in a Cellular Model of Parkinson’s Disease
    Alina Khan, Tengfei Wan, Catherine Hunter, Pavel Schweizer, Abbas Ishaq, Shobha Nagarathanam, Julia Morris, Minyu Chan, Gabriele Christine Saretzki · 2019 · OBM Neurobiology
  34. Inflammasome and neurodegenerative diseases
    Kishore Aravind Ravichandran, Michael Thomas Heneka · 2022 · Elsevier eBooks
  35. Parkinson’s disease-derived α-Synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype
    Cansu Yildirim, Alexis Fenyi, Pierre Besnault, Lina Gomez, Julia Elisa Sepulveda-Diaz, Patrick Pierre Michel, Ronald Melki, Stéphane Hunot · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Microglial involvement in brain physiopathology: in vitro studies using rat primary cultures
    Ilaria Mengoni · 2014 · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna)
  37. Effects of Aggregated Alpha-Synuclein on Cultured Neuronal Cells
    David W. Freeman · 2015 · Loyola eCommons (Loyola University of Chicago)
  38. A bioluminescence sensor of NLRP3 inflammasome activation
    Michael A. Winek · 2016 · Loyola eCommons (Loyola University of Chicago)
  39. Aging and Microglial Activation in Neurodegenerative Diseases
    Esteban A. Oyarzabal, Yen‐Yu Ian Shih, Jau‐Shyong Hong · 2016 · Oxidative stress in applied basic research and clinical practice
  40. Inflammasome-mediated activation of microglia : Tissue-specific features of innate immunity
    Saskia Maria Burm · 2016 · Utrecht University Repository (Utrecht University)
  41. Submicron Crystals of the Parkinson’s Disease Substantia nigra : Calcium Oxalate, Titanium Dioxide and Iron Oxide
    Adam Heller, Sheryl S. Coffman · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  42. The role of tyrosine phosphorylation in inflammasome complex formation and function.
    Bezaleel Mambwe · 2018 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
  43. A Role for the NLR Family Members NLRC4 And NLRP3 in Astrocytic Inflammasome Activation and Astrogliosis
    Leslie C. Freeman · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  44. Microglial Mitophagy and Neurodegenerative Disorders
    Eyitayo Adeyemi Oyindamola, Maxwell Kwadwo Agyemang, Joseph Owusu-Sarfo, Kofi Oduro Yeboah, Newman Osafo · 2020 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  45. Insulin resistance and Parkinson’s disease
    A. A. Farooqui · 2020 · Elsevier eBooks
  46. Public Relations Management Strategy for the Kalamazoo Institute of Arts
    Stephanie K Locke · 1997
  47. Molecular mechanisms of neurodegeneration in neurodegenerative diseases
    A. A. Farooqui · 2020 · Elsevier eBooks
  48. Roles in Immune Responses
    Richa M. Hanamsagar, Sandra M. Cardona, Tammy Kielian, Astrid E. Cardona · 2014 · Springer eBooks
  49. Impact of aging on the central nervous system: Approaches for antiaging
    Görkem Yavaş, Melike Mut · 2022 · Elsevier eBooks
  50. LRRK2-G2019S Synergizes With Ageing and Low-Grade Inflammation to Promote Gut and Peripheral Immune Cell Activation That Precede Nigrostriatal Degeneration
    Bianca Marchetti, Carmela Giachino, Cataldo Tirolo, Salvatore Caniglia, Maria Francesca Serapide, Francesca L’Episcopo, Federico Bertoli, Claudio Giuliano, Marika Mearelli, Meike Jakobi et al. · 2022 · Research Square
  51. Transcriptome-guided optimization of in vitro culture conditions to study microglia in health and disease
    Raissa Timmerman · 2022
  52. Amyloids as endogenous toxicants in neurodegenerative diseases
    Laura Vegas‐Gomez, Inés Lopez Del Castillo, Antonia Gutiérrez, Inés Moreno‐González · 2024 · Elsevier eBooks
  53. The interplay between CB 2 and NMDA receptors in Parkinson’s disease
    Jaume Lillo, Iu Raïch, Joan Biel Rebassa, Toni Capó, Pau Badia, Gemma Navarro, Irene Reyes‐Resina · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  54. Regulated cell death and inflammaging in neurodegenerative disorders
    Huicong Liu, Shuo Wen, Xiaoxi Gao, Can Wu, Birou Lai, Jiangli Zhu, Eryan Kong · 2025 · Elsevier eBooks
  55. CircPhc3 promotes the repair of intestinal mucosa after burn injury through the TRIM28-mediated hnRNPK SUMOylation stability modification mechanism
    Xiaoqing Xu, Yiwen Wang, Simiao Chen, Fanze Meng, Ran Li, Hao Zhang, Chao Meng, Mengmeng Zhuang, Yong Jiang Sun · 2025 · European Journal of Pharmacology
  56. PHLPP1 deficiency alleviates dopaminergic neurodegeneration and represses neuroinflammation in Parkinson’s disease
    Zhilin Chen, Yuan Liu, Jinyue Zhao, Xin‐Fu Zhou, Yudi Han, Zikai Zhou, Huazheng Liang, Yong Bi · 2025 · Behavioral and Brain Functions
  57. Tetramethylpyrazine-caffeic Acid Hybrid CT-011 Exerts Dopaminergic Neuroprotection Through Inhibiting Microglia-mediated Neuroinflammation
    Min Xie, Cheng Yu, Li Chun Yang, Zijin Lin, Hao Shen, Xinhua Zhou, Zheng Liu, Jieyu Xing, Sigui Zhou, Haiyun Chen · 2025 · Molecular Neurobiology
  58. Th2 cell-derived exosomes alleviate central nervous system inflammation and demyelination in experimental autoimmune encephalomyelitis by regulating inflammasomes to inhibit microglia activation
    Xianmin Cao, Yufen Peng, Shimin Liu, Chao Zhou, Liang Gao, Jiajun Xiong, Meihong Zhou, Mengqi Xia, Yingqiong Xiong · 2025 · Molecular Biology Reports
  59. Mecanismos fisiopatogénicos involucrados en la patología ósea de la Enfermedad de Gaucher
    Juan M. Mucci · 2014
  60. Additional file 1 of Parkinson’s disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype
    Cansu Yildirim-Balatan, Alexis Fenyi, Pierre Besnault, Gomez, Lina, Julia Elisa Sepulveda-Diaz, Patrick Pierre Michel, Melki, Ronald, Stéphane Hunot · 2024 · Figshare
  61. Additional file 1 of Integrin Mac1 mediates paraquat and maneb-induced learning and memory impairments in mice through NADPH oxidase–NLRP3 inflammasome axis-dependent microglial activation
    Hou, Liyan, Jianing Liu, Sun, Fuqiang, Ruixue Huang, Chang, Rui, Zhengzheng Ruan, Wang, Ying, Jie Zhao, Wang, Qingshan · 2023 · Figshare
  62. Neuroprotective effect of sinomenine on parkinson’s disease through NLRP3/Caspase-1/GSDMD pathway-mediated pyroptosis inhibition
    Xi Bao, JingCai Xu, Jia Zhou, Luyi Huang, Haichang Li, Yun Huang · 2026 · Metabolic Brain Disease
  63. Neurological implications of cytokine storm and oxidative stress in COVID-19: pathophysiological insights and clinical perspectives
    Hadi Rezaei Matanaq, Alireza Mohammadzadeh, Elham Sheykhsaran, Amin Abbasi, Abolfazl Jafari-Sales, Reyhaneh Rasizadeh, Hossein Bannazadeh Baghi · 2026 · Future Virology
  64. Étude de la régulation de l'inflammasome AIM2 dans des macrophages infectés par Francisella tularensis
    Carole Juruj · 2013 · theses.fr (ABES)
  65. Le rôle d'HSP70 sur l'activation de l'inflammasome NLRP3
    Pierre Martine · 2017
  66. In vitro and in vivo study of the effects of Levetiracetam on activated microglia during sepsis
    Renaud Fleurance · 2021 · theses.fr (ABES)
  67. Etude de la coopération de l'alpha-synucléine et de LRRK2 dans les dysfonctions mitochondriales dans la Maladie de Parkinson
    Camille Gardier · 2019 · theses.fr (ABES)
  68. Evaluation of an In Situ Polymerizing Hydrogel Scaffold as a Brain Delivery System for Parkinson’s Disease therapeutics
    Francesco Gubinelli · 2019 · theses.fr (ABES)
  69. Étude de la composante neuroinflammatoire dans les DFT/SLA
    Julie Smeyers · 2020 · theses.fr (ABES)
  70. Étude moléculaire de l'inflammation chronique dans la maladie de Parkinson
    Anne‐Claire Compagnion · 2019 · theses.fr (ABES)
  71. Towards the identification of targets and markers of Parkinson’s disease-associated neuroinflammation
    Cansu Yildirim-Balatan · 2021 · theses.fr (ABES)
  72. Brain-muscle axis regulation of neuroinflammation and sarcopenia in Parkinson’s disease: the bridging role of lactylation
    Maoyuan Wang, Huiwen Huang, Xiyan Lan, An Yin, Qiong Deng, Yanbiao Zhong, MaoYuan Wang · 2026 · Neurological Sciences
  73. Unconventional Protein Secretion in the Central Nervous System: Mechanisms and Roles in Physiology and Disease
    Steven A. Krauklis, Sevnur Kömürlü Keceli, Edward M. Campbell, Prabhodh S. Abbineni · 2026 · Journal of Neurochemistry
  74. MiR-7 in neurological disorders: beyond metabolic dysregulation
    Cristina Puigdueta, Virginia Pardo, Marta Torrecilla-Parra, Mario Fernández-de Frutos, José Luis López-Aceituno, Carmen Zamora, Yaiza López-Manchedo, Rebeca Busto, Cristina M. Ramírez · 2026 · Frontiers in Neuroscience
  75. Translational Insights into α-Synuclein Aggregation and Proteostasis Dysfunction in Parkinson’s Disease
    SB Paul, Abhideep Roy, Pallab Bhattacharya, Dulal Chandra Boruah, Anupom Borah · 2026 · Current Pharmacology Reports
  76. Use of receptor and nonreceptor tyrosine kinase inhibitors and Parkinson disease risk
    Giovanni R. Malaty, Jordan A. Killion, Sai Anmisha Doddamreddy, Osvaldo Laurido-Soto, Brad Alan Racette · 2026 · Neurotherapeutics
  77. RNA interference in neurological disorders: Silencing harmful immune responses
    Mohd Farhan, Md Sahidul Islam, Yogesh Srivastava, Jyotsana Singh, Hamda Khan, Qingyu Zhang · 2026 · Elsevier eBooks
  78. Biologically-synthesized zinc oxide nanoparticle-based α-synuclein nanoformulation mitigates Parkinson's disease progression in Drosophila melanogaster
    Sonali Jena, Kumari Subham, Harshit Kalra, Seekha Naik, Dibyam Debasish Sahu, Monalisa Mishra, Suman Jha · 2026 · International Journal of Biological Macromolecules
  79. Discovery of a brain penetrant NLRP3 inflammasome inhibitor that reduces neuropathic pain in mice
    Yiming Xu, Jannatun Nayem Namme, Liuyue Yang, Yulong Xu, Savannah Biby, Qian Lü, Tony Tuck, Ashley Gomm, Nitai Sarkar, Zheng Liu et al. · 2026 · European Journal of Medicinal Chemistry
  80. Pharmacological modulation of cGAS-STING-NLRP3 signaling by nano-immunomodulators in Alzheimer and Parkinson disease
    Mohammed A. Abdel-Rasol · 2026 · Inflammopharmacology
  81. BindingDB Entry 50020493: Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders.
    BindingDB · 2024 · UC San Diego
  82. BindingDB Entry 50023683: Discovery of Potent and Brain-Penetrant Bicyclic NLRP3 Inhibitors with Peripheral and Central In Vivo Activity.
    BindingDB · 2026 · UC San Diego
  83. BindingDB Entry 50021428: Comprehensive and critical view on the anti-inflammatory and immunomodulatory role of natural phenolic antioxidants.
    BindingDB · 2025 · UC San Diego
  84. BindingDB Entry 50011122: Design, synthesis and identification of N, N-dibenzylcinnamamide (DBC) derivatives as novel ligands for α-synuclein fibrils by SPR evaluation system.
    BindingDB · 2021 · UC San Diego
  85. BindingDB Entry 50017323: Discovery and Optimization of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome Inhibitors.
    BindingDB · 2023 · UC San Diego
  86. BindingDB Entry 50044870: Electrophilic warhead-based design of compounds preventing NLRP3 inflammasome-dependent pyroptosis.
    BindingDB · 2016 · UC San Diego
  87. THE ROLE OF INFLAMMASOME AND CASPASE-1 IN REGULATING ADAPTIVE RESPONSE TO OXIDATIVE STRESS IN MOUSE HEPATOCYTES
    Qian Sun · 2013 · D-Scholarship@Pitt (University of Pittsburgh)